Compound for Alzheimer's combats bacterial resistance to last-resort antibiotics in mice

November 18, 2020

An experimental drug for neurodegenerative diseases can also reverse resistance to "last-resort" polymyxin antibiotics among bacteria that cause sepsis, a life-threatening complication from infections. The findings in mice suggest that repurposing the compound, named PBT2, could help clinicians cope with the issue of polymyxin resistance, which poses a grave threat to patients with bacterial infections. Sepsis can occur in patients with infections caused by various species of bacteria, including the gram-negative species Escherichia coli, Pseudomonas aeruginosa, and Klebsiella pneumoniae. The spread of antibiotic resistance has made sepsis even more dangerous, as many of these bacteria have become resistant to both first-line antibiotics and to polymyxin antibiotics, which are only used when all other options have failed. One potential solution involves studying and repurposing drugs intended for other diseases, to try to target bacteria that have acquired antibiotic resistance. David De Oliveira and colleagues applied this approach to PBT2, an experimental compound being tested in phase 2 trials to treat Huntington's disease and Alzheimer's disease. The scientists found that PBT2 disrupted metals such as iron and zinc in polymyxin-resistant K. pneumoniae and P. aeruginosa, which resensitized the bacteria to polymyxin treatment. Combining PBT2 with polymyxin also substantially boosted survival rates and lowered bacterial loads in mice with sepsis caused by a highly invasive, polymyxin-resistant strain of K. pneumoniae. The authors call for further work to establish the safety and clinical potential of combining PBT2 with polymyxin antibiotics in humans.
-end-


American Association for the Advancement of Science

Related Bacteria Articles from Brightsurf:

Siblings can also differ from one another in bacteria
A research team from the University of Tübingen and the German Center for Infection Research (DZIF) is investigating how pathogens influence the immune response of their host with genetic variation.

How bacteria fertilize soya
Soya and clover have their very own fertiliser factories in their roots, where bacteria manufacture ammonium, which is crucial for plant growth.

Bacteria might help other bacteria to tolerate antibiotics better
A new paper by the Dynamical Systems Biology lab at UPF shows that the response by bacteria to antibiotics may depend on other species of bacteria they live with, in such a way that some bacteria may make others more tolerant to antibiotics.

Two-faced bacteria
The gut microbiome, which is a collection of numerous beneficial bacteria species, is key to our overall well-being and good health.

Microcensus in bacteria
Bacillus subtilis can determine proportions of different groups within a mixed population.

Right beneath the skin we all have the same bacteria
In the dermis skin layer, the same bacteria are found across age and gender.

Bacteria must be 'stressed out' to divide
Bacterial cell division is controlled by both enzymatic activity and mechanical forces, which work together to control its timing and location, a new study from EPFL finds.

How bees live with bacteria
More than 90 percent of all bee species are not organized in colonies, but fight their way through life alone.

The bacteria building your baby
Australian researchers have laid to rest a longstanding controversy: is the womb sterile?

Hopping bacteria
Scientists have long known that key models of bacterial movement in real-world conditions are flawed.

Read More: Bacteria News and Bacteria Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.